MedPath

Effect of Iron Chelation Therapy on Glucose Metabolism in Non-Transfusion-Dependent Thalassemics

Not Applicable
Conditions
Subject with non&#45
transfusion dependent thalassemia with iron excess (serum ferritin >300 ng/mL)
thalassemia&#44
glucose metabolism&#44
iron chelation
Registration Number
TCTR20160523003
Lead Sponsor
o
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
All
Target Recruitment
10
Inclusion Criteria

Patients with NTDT, aged older than 10 years, with serum ferritin >300 ng/mL. All patients and/or parents provided written consent before the enrollment.

Exclusion Criteria

Known cases of type 1 or type 2 diabetes mellitus and patients, taking medications affecting glucose metabolism or iron chelation therapy within one month before the study, were excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Iron status At 6 months Serum ferritin, MRI study
Secondary Outcome Measures
NameTimeMethod
o No No
© Copyright 2025. All Rights Reserved by MedPath